Swiss pharma industry fights lower drug prices in the US
The American subsidiaries of Swiss drug giants, Roche and Novartis, have actively participated in the lobbying of US Congress members over the proposal to lower drug prices in the US. Copyright 2017 The Associated Press. All Rights Reserved.
A proposed law currently under discussion in the United States Congress aims to lower prescription drug prices. But Big Pharma, including Swiss giants Roche and Novartis, are pulling out all the stops to lobby against the measure.
This content was published on May 24, 2021 - 10:11
May 24, 2021 - 10:11
Alexis Rapin, Montréal
The issue often sparks heated debate across the Atlantic. The cost of prescription drugs in the US is among the highest in the world, with many Americans regularly forced to bleed themselves dry just to pay their pharmaceutical bills. Written in 2019 and dusted off last April, draft legislation to reform the law is currently being discussed by Congress. It’s a m
A Modest Step Toward Entitlement Reform
A bipartisan coalition has introduced legislation to keep Social Security and Medicare solvent.
(Photograph by Samuel Corum/Getty Images)
It has been said that Washington has two standard responses to America’s challenges: do nothing, or overreact. We are all witnessing President Biden’s $6 trillion overreaction to the (improving) economy and our (very loosely defined) infrastructure needs. At the same time, Washington is doing nothing about an economic challenge that will ultimately cost many times more than $6 trillion and risk the economic security of tens of millions of Americans: the collapsing finances of the Social Security and Medicare systems.
Centrist Democrats signal disaster for Nancy Pelosi s drug plan washingtontimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtontimes.com Daily Mail and Mail on Sunday newspapers.